Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Patient Selection"" wg kryterium: Temat


Tytuł :
COVID: treatment trials are still urgent.
Autorzy :
Rauchman S
Pokaż więcej
Źródło :
Nature [Nature] 2021 Jun; Vol. 594 (7861), pp. 26.
Typ publikacji :
Letter
MeSH Terms :
Patient Selection*
COVID-19/*drug therapy
COVID-19 Vaccines/*supply & distribution
Immunization Programs/*statistics & numerical data
Randomized Controlled Trials as Topic/*methods
COVID-19/mortality ; COVID-19/prevention & control ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; Humans ; India/epidemiology ; Pandemics ; SARS-CoV-2/pathogenicity ; Time Factors ; United States/epidemiology
SCR Organism :
SARS-CoV-2 variants
Opinia redakcyjna
Tytuł :
Effect of Opt-In vs Opt-Out Framing on Enrollment in a COVID-19 Surveillance Testing Program: The COVID SAFE Randomized Clinical Trial.
Autorzy :
Oakes AH; VA Health Services Research & Development Center for Health Equity Research and Promotion, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.; Penn Medicine Nudge Unit, University of Pennsylvania, Philadelphia.
Epstein JA; Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Ganguly A; Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Genetic Diagnostic Laboratory, Department of Genetics, University of Pennsylvania, Philadelphia.
Park SH; Penn Medicine Nudge Unit, University of Pennsylvania, Philadelphia.
Evans CN; Penn Medicine Nudge Unit, University of Pennsylvania, Philadelphia.
Patel MS; VA Health Services Research & Development Center for Health Equity Research and Promotion, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.; Penn Medicine Nudge Unit, University of Pennsylvania, Philadelphia.; Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Wharton School, University of Pennsylvania, Philadelphia.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 Jun 01; Vol. 4 (6), pp. e2112434. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/diagnosis
COVID-19 Testing*
Choice Behavior*
Patient Selection*
Research Subjects*
Data Collection/*methods
Population Surveillance/*methods
Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Eligibility criteria for menopausal hormone therapy (MHT): A consortium of scientific societies for the use of MHT in women with medical conditions. Research protocol.
Autorzy :
Mendoza N; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia -AEEM). Electronic address: .
Ramírez I; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia -AEEM).
De la Viuda E; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia -AEEM).
Vázquez JC; Biomedical Research Institute Sant Pau (IIB Sant Pau).
Solá I; Biomedical Research Institute Sant Pau (IIB Sant Pau); CIBER Epidemiología y Salud Pública (CIBERESP).
Cano A; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia -AEEM).
Pokaż więcej
Źródło :
Maturitas [Maturitas] 2021 Jun; Vol. 148, pp. 14-17. Date of Electronic Publication: 2021 Apr 04.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Research Design*
Hormone Replacement Therapy/*methods
Hormone Replacement Therapy/*standards
Menopause/*drug effects
Societies, Scientific/*organization & administration
Female ; Humans ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł :
Improving recruitment to clinical trials for regional and rural cancer patients through a regionally based clinical trials network.
Autorzy :
Muthusamy A; Border Medical Oncology, Albury, NSW.
Long D; Regional Trials Network Victoria, Albury, NSW.
Underhill CR; Border Medical Oncology, Albury, NSW.; Rural Clinical School, UNSW, Albury, NSW.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 453-454.e1. Date of Electronic Publication: 2021 May 14.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Patient Selection*
Neoplasms/*therapy
Rural Health Services/*organization & administration
Australia ; Health Services Accessibility ; Healthcare Disparities ; Humans ; Rural Population
Czasopismo naukowe
Tytuł :
Clinical and Demographic Factors Influence Clinical Trial Enrollment.
Autorzy :
Suto DJ; Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego CA 619-543-7760, USA. Electronic address: .
Perrinez E; Department of Quality and Patient Safety, University of California San Diego Health, San Diego, CA 619-543-1982 USA. Electronic address: .
Rapp KS; Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego CA 619-543-7760, USA. Electronic address: .
Nabulsi M; Department of Quality and Patient Safety, University of California San Diego Health, San Diego, CA 619-543-1982 USA. Electronic address: .
Hemmen TM; Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego CA 619-543-7760, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Jun; Vol. 30 (6), pp. 105771. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Eligibility Determination*
Patient Selection*
Ischemic Stroke/*diagnosis
Ischemic Stroke/*epidemiology
Age Factors ; Aged ; Bias ; Comorbidity ; Databases, Factual ; Female ; Health Status ; Humans ; Ischemic Stroke/therapy ; Male ; Middle Aged ; Race Factors ; Risk Factors ; Social Determinants of Health ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained.
Autorzy :
Olchanski N; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street #63, Boston, MA, 02111, USA. .
van Klaveren D; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street #63, Boston, MA, 02111, USA.
Cohen JT; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street #63, Boston, MA, 02111, USA.
Wong JB; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street #63, Boston, MA, 02111, USA.; Division of Clinical Decision Making, Tufts Medical Center, Boston, MA, USA.
Ruthazer R; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street #63, Boston, MA, 02111, USA.
Kent DM; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street #63, Boston, MA, 02111, USA.
Pokaż więcej
Źródło :
Acta diabetologica [Acta Diabetol] 2021 Jun; Vol. 58 (6), pp. 707-722. Date of Electronic Publication: 2021 Jan 30.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Primary Prevention*/economics
Primary Prevention*/methods
Primary Prevention*/organization & administration
Primary Prevention*/statistics & numerical data
Diabetes Mellitus, Type 2/*prevention & control
Prediabetic State/*therapy
Adult ; Cohort Studies ; Cost-Benefit Analysis ; Diabetes Mellitus, Type 2/economics ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Health Services Accessibility/economics ; Health Services Accessibility/organization & administration ; Health Services Accessibility/statistics & numerical data ; Humans ; Hypoglycemic Agents/economics ; Hypoglycemic Agents/therapeutic use ; Life Expectancy ; Life Style ; Male ; Metformin/economics ; Metformin/therapeutic use ; Middle Aged ; Prediabetic State/economics ; Prediabetic State/epidemiology ; Quality of Life ; Risk Factors ; Standard of Care/economics ; Standard of Care/organization & administration ; Standard of Care/standards ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Pirfenidone in patients with non-IPF progressive fibrotic interstitial lung diseases: expert guidance is urgently needed.
Autorzy :
Wells AU; Royal Brompton Hospital, London, SW3 6HP, UK; Imperial College, London, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 May; Vol. 9 (5), pp. 437-438. Date of Electronic Publication: 2021 Mar 30.
Typ publikacji :
Journal Article
MeSH Terms :
Endpoint Determination*/methods
Endpoint Determination*/standards
Health Services Needs and Demand*
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/physiopathology
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/drug therapy
Lung Diseases, Interstitial*/physiopathology
Patient Selection*
Pyridones/*pharmacology
Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Clinical Trials as Topic ; Early Termination of Clinical Trials ; Humans ; Intention to Treat Analysis/methods ; Practice Guidelines as Topic ; Respiratory Function Tests/methods
Czasopismo naukowe
Tytuł :
Severe mental illness and European COVID-19 vaccination strategies.
Autorzy :
De Picker LJ; Scientific Initiative for Neuropsychiatric and Pyschopharmacological Studies, University Psychiatric Hospital Campus Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium. Electronic address: .
Dias MC; National Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK; Section of Women's Mental Health, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
Benros ME; Copenhagen Research Centre for Mental Health, Copenhagen University Hospital, Copenhagen, Denmark; Department of Immunology & Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Vai B; Psychiatry & Clinical Psychology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Fondazione Centro San Raffaele, Milan, Italy.
Branchi I; Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
Benedetti F; Psychiatry & Clinical Psychology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Psychiatry and Clinical Psychobiology Unit, University Vita-Salute San Raffaele, Milan, Italy.
Borsini A; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
Leza JC; Department of Pharmacology & Toxicology, Faculty of Medicine, Universidad Complutense Madrid, CIBERSAM, Madrid, Spain.
Kärkkäinen H; Global Alliance of Mental Illness Advocacy Networks-Europe, Brussels, Belgium.
Männikkö M; European Federation of Associations of Families of People with Mental Illness, Leuven, Belgium.
Pariante CM; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
Güngör ES; University of Health Sciences, Erenköy Mental Health and Neurological Diseases Training and Research Hospital, Istanbul, Turkey.
Szczegielniak A; Department of Psychiatric Rehabilitation, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland.
Tamouza R; IMRB Translational Neuropsychiatry Lab, Université Paris Est Creteil, Creteil, France; Department of Psychiatry and Addictology, Hôpitaux Universitaires Henri Mondor, Créteil, France; Fondation FondaMental, Creteil, France.
van der Markt A; Amsterdam UMC, Vrije Universiteit Amsterdam, Psychiatry, Amsterdam Public Health Research Institute, The Netherlands.
Fusar-Poli P; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Beezhold J; Norwich Medical School, University of East Anglia, Norwich, UK; Mental Health Liaison Service, Norfolk and Norwich University Hospital, Norfolk and Suffolk NHS Foundation Trust, Norwich, UK.
Leboyer M; IMRB Translational Neuropsychiatry Lab, Université Paris Est Creteil, Creteil, France; Department of Psychiatry and Addictology, Hôpitaux Universitaires Henri Mondor, Créteil, France; Fondation FondaMental, Creteil, France.
Pokaż więcej
Źródło :
The lancet. Psychiatry [Lancet Psychiatry] 2021 May; Vol. 8 (5), pp. 356-359. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Immunization Programs*/ethics
Immunization Programs*/methods
Immunization Programs*/statistics & numerical data
Patient Selection*
Mental Disorders/*epidemiology
Europe/epidemiology ; Humans ; Needs Assessment ; Risk Adjustment/methods ; SARS-CoV-2 ; Vaccination Coverage/organization & administration
Czasopismo naukowe
Tytuł :
Benchmarking Outcomes: Reoperation for Aortic Valve Patient-Prosthesis Mismatch.
Autorzy :
Keeling WB; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. Electronic address: .
Beckerman Z; Departments of Pediatrics and Surgery and Perioperative Care, Dell Children's Medical Center of Central Texas, Austin, Texas.
Wei J; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Binongo J; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Leshnower BG; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
Chen EP; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2021 May; Vol. 111 (5), pp. 1472-1477. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Benchmarking*
Echocardiography*
Heart Valve Prosthesis*/adverse effects
Patient Selection*
Aortic Valve/*diagnostic imaging
Aortic Valve/*surgery
Heart Valve Diseases/*surgery
Postoperative Complications/*diagnostic imaging
Reoperation/*standards
Aged ; Female ; Humans ; Male ; Middle Aged ; Postoperative Complications/etiology ; Prosthesis Design ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Site of Deep Venous Thrombosis and Age in the Selection of Patients in the Emergency Department for Hospitalization Versus Home Treatment.
Autorzy :
Stein PD; Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan. Electronic address: .
Matta F; Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan.
Hughes MJ; Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 May 01; Vol. 146, pp. 95-98. Date of Electronic Publication: 2021 Jan 30.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Patient Selection*
Emergency Service, Hospital/*statistics & numerical data
Hospitalization/*statistics & numerical data
Venous Thrombosis/*diagnosis
Acute Disease ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Venous Thrombosis/therapy
Czasopismo naukowe
Tytuł :
Informing COVID-19 vaccination priorities based on the prevalence of risk factors among adults in Canada.
Autorzy :
McAlister FA; Department of Medicine (McAlister, Saxinger), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta.; Health Analysis Division (Bushnik), Statistics Canada, Ottawa, Ont.; Department of Medicine (Leung), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Alberta Health Services (Saxinger), Edmonton, Alta. .
Bushnik T; Department of Medicine (McAlister, Saxinger), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta.; Health Analysis Division (Bushnik), Statistics Canada, Ottawa, Ont.; Department of Medicine (Leung), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Alberta Health Services (Saxinger), Edmonton, Alta.
Leung AA; Department of Medicine (McAlister, Saxinger), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta.; Health Analysis Division (Bushnik), Statistics Canada, Ottawa, Ont.; Department of Medicine (Leung), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Alberta Health Services (Saxinger), Edmonton, Alta.
Saxinger L; Department of Medicine (McAlister, Saxinger), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta.; Health Analysis Division (Bushnik), Statistics Canada, Ottawa, Ont.; Department of Medicine (Leung), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Alberta Health Services (Saxinger), Edmonton, Alta.
Pokaż więcej
Źródło :
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2021 Apr 26; Vol. 193 (17), pp. E617-E621. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Selection*
COVID-19/*prevention & control
COVID-19 Vaccines/*therapeutic use
Immunization Programs/*organization & administration
Canada ; Health Equity ; Humans ; Vaccination/statistics & numerical data
Czasopismo naukowe
Tytuł :
The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
Autorzy :
Sethi S; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK. .
Kumar A; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK.
Mandal A; University of Birmingham, Birmingham, UK.
Shaikh M; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.
Hall CA; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.
Kirk JMW; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.; Research Institute in Healthcare Sciences (RIHS), University of Wolverhampton, Wolverhampton, UK.
Moss P; University of Birmingham, Birmingham, UK.
Brookes MJ; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK.; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.; Research Institute in Healthcare Sciences (RIHS), University of Wolverhampton, Wolverhampton, UK.
Basu S; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK.; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.; Research Institute in Healthcare Sciences (RIHS), University of Wolverhampton, Wolverhampton, UK.
Pokaż więcej
Źródło :
Trials [Trials] 2021 Apr 20; Vol. 22 (1), pp. 296. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Patient Selection*
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Surveys and Questionnaires ; United Kingdom ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Center-Level Variations in Maximum Recipient Body Mass Index in Heart Transplantation.
Autorzy :
Fisher BW; Division of Cardiac Surgery at the University of Pittsburgh Medical Center, Pittsburgh Pennsylvania.
Huckaby LV; Division of Cardiac Surgery at the University of Pittsburgh Medical Center, Pittsburgh Pennsylvania.
Sultan I; Division of Cardiac Surgery at the University of Pittsburgh Medical Center, Pittsburgh Pennsylvania.
Hickey G; Division of Cardiac Surgery at the University of Pittsburgh Medical Center, Pittsburgh Pennsylvania.
Kilic A; Division of Cardiac Surgery at the University of Pittsburgh Medical Center, Pittsburgh Pennsylvania. Electronic address: .
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Apr 15; Vol. 145, pp. 91-96. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article
MeSH Terms :
Mortality*
Patient Selection*
Heart Failure/*surgery
Heart Transplantation/*methods
Hospitals/*statistics & numerical data
Obesity, Morbid/*epidemiology
Adult ; Aged ; Body Mass Index ; Female ; Heart Failure/epidemiology ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Obesity/epidemiology ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future.
Autorzy :
Martino D; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC. .
Deeb W; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Jimenez-Shahed J; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Malaty I; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Pringsheim TM; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Fasano A; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Ganos C; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Wu W; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Okun MS; From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.
Pokaż więcej
Źródło :
Neurology [Neurology] 2021 Apr 06; Vol. 96 (14), pp. 664-676. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Patient Selection*
Deep Brain Stimulation/*methods
Tourette Syndrome/*surgery
Humans
Czasopismo naukowe
Tytuł :
Patient Selection for Transoral Robotic Surgery (TORS) in Oropharyngeal Squamous Cell Carcinoma: What the Surgeon Wants to Know.
Autorzy :
Bunch PM; Department of Radiology Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC.
Patwa HS; Department of Otolaryngology-Head and Neck Surgery, Wake Forest School of Medicine, Winston Salem, NC.
Hughes RT; Department of Radiation Oncology, Wake Forest School of Medicine, Winston Salem, NC.
Porosnicu M; Department of Hematology and Oncology, Wake Forest School of Medicine, Winston Salem, NC.
Waltonen JD; Department of Otolaryngology-Head and Neck Surgery, Wake Forest School of Medicine, Winston Salem, NC.
Pokaż więcej
Źródło :
Topics in magnetic resonance imaging : TMRI [Top Magn Reson Imaging] 2021 Apr 01; Vol. 30 (2), pp. 117-130.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Robotic Surgical Procedures*
Surgeons*
Oropharyngeal Neoplasms/*surgery
Squamous Cell Carcinoma of Head and Neck/*surgery
Aged ; Female ; Humans ; Male ; Middle Aged ; Oropharyngeal Neoplasms/pathology ; Squamous Cell Carcinoma of Head and Neck/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Limited use of extracorporeal CO2 removal].
Autorzy :
Intven FA; Catharina Ziekenhuis, afd. Intensive Care, Eindhoven.; Contact: Femke A. Intven ().
Bindels AJ; Catharina Ziekenhuis, afd. Intensive Care, Eindhoven.
van der Hoeven JG; Radboudumc, afd. Intensive Care, Nijmegen.
Heunks LMAMA; Amsterdam UMC, afd. Intensive Care, Amsterdam.
Pokaż więcej
Transliterated Title :
Extracorporele CO2-verwijdering beperkt toegepast.
Źródło :
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2021 Apr 01; Vol. 165. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Critical Care*
Patient Selection*
Carbon Dioxide/*blood
Extracorporeal Membrane Oxygenation/*methods
Hypercapnia/*therapy
Respiration, Artificial/*methods
Humans
Czasopismo naukowe
Tytuł :
The Psychosocial Assessment of Transplant Candidates: Internal Consistency, Interrater Reliability, and Content Validity of the Thai Version of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT-Thai Version).
Autorzy :
Thisayakorn P; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: .
Sakunwetsa D; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Tangwongchai S; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Jirakran K; Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Lolak S; Department of Psychiatry, Virginia Commonwealth University, Inova Fairfax Medical Campus, Fairfax, Virginia.
Maldonado JR; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2021 Apr; Vol. 53 (3), pp. 779-785. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Patient Selection*
Organ Transplantation/*psychology
Surveys and Questionnaires/*standards
Transplant Recipients/*psychology
Adult ; Female ; Humans ; Male ; Middle Aged ; Preoperative Period ; Reproducibility of Results ; Thailand ; Translations
Czasopismo naukowe
Tytuł :
Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients.
Autorzy :
Daoud A; Cairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt. Electronic address: .
Soliman K; Medical University of South Carolina, Charleston, South Carolina, USA.
Teeter L; Forensic Research & Analysis, Portland, Oregon, USA.
Ali H; University of Birmingham, Birmingham, UK.
Graviss EA; Houston Methodist Hospital, Houston, Texas, USA.
Mogawer S; Cairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.
Sholkamy A; Cairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.
El-Shazli M; Cairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.
Gaber AO; Houston Methodist Hospital, Houston, Texas, USA.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2021 Apr; Vol. 53 (3), pp. 833-838. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Patient Selection*
Carcinoma, Hepatocellular/*blood
Liver Neoplasms/*blood
Liver Transplantation/*mortality
alpha-Fetoproteins/*analysis
Adult ; Biomarkers/blood ; Carcinoma, Hepatocellular/surgery ; Female ; Humans ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Severity of Illness Index ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?
Autorzy :
Abel GA; Dana-Farber Cancer Institute, Boston, MA, USA. .
Kim HT; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard School of Public Health, Boston, MA, USA.
Hantel A; Dana-Farber Cancer Institute, Boston, MA, USA.
Steensma DP; Dana-Farber Cancer Institute, Boston, MA, USA.
Stone R; Dana-Farber Cancer Institute, Boston, MA, USA.
Habib A; Dana-Farber Cancer Institute, Boston, MA, USA.
Ho VT; Dana-Farber Cancer Institute, Boston, MA, USA.
Wadleigh M; Dana-Farber Cancer Institute, Boston, MA, USA.
El-Jawahri A; Massachusetts General Hospital, Boston, MA, USA.
Alyea EP; Duke Cancer Institute, Durham, NC, USA.
DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA.
Koreth J; Dana-Farber Cancer Institute, Boston, MA, USA.
Antin JH; Dana-Farber Cancer Institute, Boston, MA, USA.
Soiffer RJ; Dana-Farber Cancer Institute, Boston, MA, USA.
Cutler C; Dana-Farber Cancer Institute, Boston, MA, USA.
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1166-1175. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Selection*
Myelodysplastic Syndromes/*diagnosis
Age Factors ; Aged ; Biomarkers ; Clinical Decision-Making ; Disease Management ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Male ; Middle Aged ; Mutation ; Myelodysplastic Syndromes/genetics ; Myelodysplastic Syndromes/mortality ; Myelodysplastic Syndromes/therapy ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Severity of Illness Index ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies